1999
DOI: 10.1038/sj.mp.4000529
|View full text |Cite
|
Sign up to set email alerts
|

Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and α2-adrenergic agonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
65
0

Year Published

2000
2000
2009
2009

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 82 publications
(68 citation statements)
references
References 36 publications
3
65
0
Order By: Relevance
“…In vivo microdialysis study indicated that the administration of dizocilpine (0.5 mg/kg) increased significantly the extracellular levels of ACh in rat retrosplenial cortex, as previously reported (Kim et al, 1999). Pretreatment with CCPA (1 or 3 mg/kg, i.p.)…”
Section: Figuresupporting
confidence: 86%
See 2 more Smart Citations
“…In vivo microdialysis study indicated that the administration of dizocilpine (0.5 mg/kg) increased significantly the extracellular levels of ACh in rat retrosplenial cortex, as previously reported (Kim et al, 1999). Pretreatment with CCPA (1 or 3 mg/kg, i.p.)…”
Section: Figuresupporting
confidence: 86%
“…It has been reported that systemic administration of GABAergic agonists (diazepam and pentobarbital), the a 2 -adrenergic agonist clonidine, and the novel metabotropic glutamate receptor agonist LY 379268 significantly suppressed both dizocilpine-induced neuronal vacuolization and ACh release in the rat retrosplenial cortex (Kim et al, 1999;Okamura et al, in press). Interestingly, local injection of clonidine to the retrosplenial cortex did not reduce extracellular Ach levels or the number of vacuolized neurons, whereas local injection to the basal forebrain, where the majority of the cortical-projecting cholinergic neurons exist, significantly reduced the number of vacuolized neurons (Farber et al, 2002).…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…Jackson et al (2004) have shown that MK-801, at the doses used in the present study, increases irregular firing and decreases organized burst firing of neurons in the prefrontal cortex. These chaotic changes in neuronal firing may reflect excessive cortical neurotransmitter (eg acetylcholine, glutamate, dopamine) release evoked by NMDA antagonists (Kim et al, 1999;Moghaddam and Adams, 1998) Clonidine, on the other hand, has been shown to suppress elevations in neurotransmitter release induced by various perturbations, including MK-801 (Acquas et al, 1998;Jellish et al, 2005;Kim et al, 1999). Clonidine's suppressive effect on neurotransmitter release may be due to its direct action on presynaptic terminals (Kamisaki et al, 1992) or indirect effects on neuronal firing (Kawahara et al, 2001).…”
Section: Discussionmentioning
confidence: 99%
“…Increasing evidence supports the notion that neurochemical changes secondary to NMDA receptor hypofunction directly mediate these cognitive deficits, inasmuch as pharmacologic strategies working on nonglutamatergic systems can be effective at alleviating cognitive impairments in NMDA antagonist-treated animals (Jentsch and Anzivino, 2004;Verma and Moghaddam, 1996). For example, activation of dopaminergic and cholinergic systems triggered by NMDA blockade mediate both behavioral and neurotoxic effects of PCP and related drugs (Kim et al, 1999;Verma and Moghaddam, 1996), and an overall increase in excitatory glutamatergic transmission is thought to link NMDA receptor hypofunction to altered function of these reticular systems (Moghaddam et al, 1997).…”
Section: Introductionmentioning
confidence: 95%